☆ 4.6 Article

Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study

NEURO-ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Daniel Dubinski et al.

Summary: GBM patients with postoperative PE showed no significant difference in major intracranial hemorrhage, re-thrombosis, or re-embolism between those receiving DOACs and LMWH. However, a tendency towards reduced mRS at 6 and 12 months was observed in the LMWH cohort, while patients receiving DOACs had a statistical benefit in overall survival. Prospective, randomized trials are needed to further evaluate the use of DOACs for therapeutic anticoagulation in GBM patients with PE.

NEUROSURGICAL REVIEW (2022)

添加到收藏夹

Article Oncology

Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?

Jasmin Jo et al.

Summary: This study aimed to assess the risk of intracranial hemorrhage (ICH) in high-grade glioma (HGG) patients with venous thromboembolism (VTE) on low molecular weight heparin (LMWH). The retrospective matched cohort study found that therapeutic LMWH is not associated with a substantially increased risk of ICH in HGG patients, and the median survival was similar among all three cohorts.

NEURO-ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies

Andrew W. Swartz et al.

Summary: This study found that patients with brain tumors using DOACs experienced fewer major bleeding events compared to those using LMWH, with similar efficacy, suggesting that DOACs are a safe and effective treatment option for these patients.

ONCOLOGIST (2021)

添加到收藏夹

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

添加到收藏夹

Review Cell Biology

Contrasts in Glioblastoma-Venous Thromboembolism versus Bleeding Risk

Viktoria Muster et al.

Summary: Glioblastoma patients have a high risk of developing venous thromboembolism, making therapeutic anticoagulation challenging with limited data available for this vulnerable patient group.

CELLS (2021)

添加到收藏夹

Article Hematology

Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Review Hematology

How I assess and manage the risk of bleeding in patients treated for venous thromboembolism

Frederikus A. Klok et al.

BLOOD (2020)

添加到收藏夹

Review Hematology

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Frits Mulder et al.

BLOOD (2020)

添加到收藏夹

Review Behavioral Sciences

Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis

Angelo Porfidia et al.

BRAIN AND BEHAVIOR (2020)

添加到收藏夹

Review Oncology

Incidence, Therapy, and Bleeding Risk-Cancer- Associated Thrombosis in Patients with Glioblastoma

Viktoria Muster et al.

CANCERS (2020)

添加到收藏夹

Article Medicine, General & Internal

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Giancarlo Agnelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Hematology

Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors

B. J. Carney et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Article Oncology

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Annie M. Young et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Hematology

Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin

Charlene Mantia et al.

BLOOD (2017)

添加到收藏夹

Article Hematology

A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation

J. I. Zwicker et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

添加到收藏夹

Article Hematology

Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study

Jessica Donato et al.

BLOOD (2015)

添加到收藏夹

Article Oncology

A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors

Michael B. Streiff et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Venous thromboembolism (VTE) and glioblastoma

Shlomit Yust-Katz et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

添加到收藏夹

Review Hematology

Epidemiology of cancer-associated venous thrombosis

Jasmijn F. Timp et al.

BLOOD (2013)

添加到收藏夹

Article Oncology

Thromboembolic disease in patients with high-grade glioma

James R. Perry

NEURO-ONCOLOGY (2012)

添加到收藏夹

Review Hematology

Venous thromboembolism in malignant gliomas

E. O. Jenkins et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

添加到收藏夹

Article Medicine, General & Internal

Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism - A meta-analysis

LA Linkins et al.

ANNALS OF INTERNAL MEDICINE (2003)

添加到收藏夹

Article Medicine, General & Internal

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

AYY Lee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.